rplC Resolved · high auto-curated

H37Rv Rv0701 · MTBC0 mtbc0_000743 · 217 aa · 804894–805547 MTBC0 (+) · RefSeq NP_215215.1

Genomic neighbourhood (genome browser)

Open in full genome browser →
+ strand − strand Rv0688 (Rv0688) — requalified: FAD/NAD(P)-binding oxidoreductase Rv0690c (Rv0690c) — family_assigned: DUF2332 domain-containing protein Rv0690c mftR (Rv0691c) — family_assigned: mycofactocin system transcriptional regulator mftB (Rv0692) — requalified: mycofactocin biosynthesis chaperone MftB mftC (Rv0693) — requalified: mycofactocin radical SAM maturase mftC mftD (Rv0694) — requalified: pre-mycofactocin synthase MftD mftD mftE (Rv0695) — requalified: mycofactocin biosynthesis peptidyl-dipeptidase MftE mftF (Rv0696) — requalified: mycofactocin biosynthesis glycosyltransferase MftF mftF mftG (Rv0697) — family_assigned: mycofactocin system GMC family oxidoreductase MftG mftG Rv0699 (Rv0699) — dark: hypothetical protein rplC (Rv0701) — requalified: 50S ribosomal protein L3 rplD (Rv0702) — requalified: 50S ribosomal protein L4 rplW (Rv0703) — requalified: 50S ribosomal protein L23 rplB (Rv0704) — requalified: 50S ribosomal protein L2 rplB rpsS (Rv0705) — requalified: 30S ribosomal protein S19 rplV (Rv0706) — requalified: 50S ribosomal protein L22 rpsC (Rv0707) — requalified: 30S ribosomal protein S3 rpsC rplP (Rv0708) — requalified: 50S ribosomal protein L16 rpmC (Rv0709) — requalified: 50S ribosomal protein L29 rpsQ (Rv0710) — requalified: 30S ribosomal protein S17 atsA (Rv0711) — requalified: arylsulfatase AtsA atsA Rv0712 (Rv0712) — family_assigned: formylglycine-generating enzyme family protein Rv0712 Rv0713 (Rv0713) — dark: DUF4436 domain-containing protein Rv0713 rplX (Rv0715) — requalified: 50S ribosomal protein L24 rplE (Rv0716) — requalified: 50S ribosomal protein L5 796 kb 800 kb 804 kb 808 kb 812 kb 816 kb

This gene (outlined) in its genomic context; arrows are neighbouring genes coloured by verdict. Click any gene to navigate. Pan and zoom in the full browser.

Annotation: from legacy to revised

Legacy (H37Rv / Mycobrowser)50S ribosomal protein L3
MTBC0 PGAP re-annotation50S ribosomal protein L3
Revised (this work)50S ribosomal protein L3. Pfam: Ribosomal_L3 (PF00297.29).
Functional category (TubercuList)information pathways

Auto-curated: this verdict and function were generated by rules from PGAP + Pfam + Foldseek and have not been hand-reviewed.

In the literature (TB corpus sweep) 50 publications

50 TB publications mention this gene. 50 publications discuss this gene. Queried separately, 42 records carry a M. tuberculosis context and 9 a non-TB mycobacterial context (species named in the 9-record verified sample: M. abscessus (7), M. leprae (1), M. marinum (1), M. smegmatis (1)). The three counts come from three distinct PubMed queries (each with its own context filter), so they neither partition the total nor need to add up to it.

5 of 50: the most recently indexed records of the curated sweep at its date, not necessarily the most recent papers on this gene — the exhaustive list below is later and broader and may hold newer ones.
PublicationDate
Resistance to Linezolid and Pretomanid in the Era of Modern Drug-Resistant Tuberculosis Treatment in South Africa: A Systematic Review and Meta-Analysis. doi:10.3390/antibiotics15060543 2026
A Case of Transmission of Bedaquiline- and Linezolid-Resistant Tuberculosis. doi:10.3390/ijms27114912 2026
Uncovering resistance pathways to first- and last-line antibiotics in Mycobacterium tuberculosis populations. doi:10.1099/mgen.0.001723 2026
A Frameshift Mutation in the Methyltransferase rlmN Is Associated with Increased Linezolid Resistance in Mycobacterium tuberculosis. doi:10.34133/csbj.0090 2026
Comparative transcriptomic profiling of pyrazinamide resistance in Mycobacterium tuberculosis. doi:10.1093/jambio/lxag064 2026
52 records returned by the alias sweep (a separate sweep from the 50 above; both are shown, neither is exhaustive)

Searched as: Rv0701, rplC, Mb0721, ML1863c, MMAR_1031, MSMEG_1436, MAB_3820c — each in conjunction with a mycobacterial context term. Swept 2026-09-07.

PublicationJournalYear
Resistance to Linezolid and Pretomanid in the Era of Modern Drug-Resistant Tuberculosis Treatment in South Africa: A Systematic Review and Meta-Analysis. doi:10.3390/antibiotics15060543 Antibiotics (Basel) 2026
A Case of Transmission of Bedaquiline- and Linezolid-Resistant Tuberculosis. doi:10.3390/ijms27114912 Int J Mol Sci 2026
Uncovering resistance pathways to first- and last-line antibiotics in Mycobacterium tuberculosis populations. doi:10.1099/mgen.0.001723 Microb Genom 2026
A Frameshift Mutation in the Methyltransferase rlmN Is Associated with Increased Linezolid Resistance in Mycobacterium tuberculosis. doi:10.34133/csbj.0090 Comput Struct Biotechnol J 2026
Comparative transcriptomic profiling of pyrazinamide resistance in Mycobacterium tuberculosis. doi:10.1093/jambio/lxag064 J Appl Microbiol 2026
Acquired linezolid resistance in DR-TB: genotype-phenotype discordance and molecular heterogeneity in a retrospective cohort. doi:10.1186/s12879-026-12869-8 BMC Infect Dis 2026
Characteristic exploration of Mycobacterium tuberculosis isolated from patients with linezolid-treated multidrug-resistant tuberculosis. doi:10.1007/s10096-025-05319-x Eur J Clin Microbiol Infect Dis 2026
Effect of Bdq-Containing Regimen and Molecular Detection of Bdq Resistance among Pre-XDR-TB Patients with Unfavorable Outcomes. doi:10.2147/IJGM.S538660 Int J Gen Med 2025
Investigation of delamanid, bedaquiline, and linezolid resistance rates and related gene mutations in multidrug-resistant Mycobacterium tuberculosis in regional tuberculosis reference laboratories of Iran. doi:10.1186/s12866-025-04213-y BMC Microbiol 2025
Dinucleotide codon substitutions as a signature of diversifying selection in Mycobacterium tuberculosis. doi:10.3389/fmolb.2025.1511372 Front Mol Biosci 2025
Comparative In Vitro Drug Susceptibility Study of Five Oxazolidinones Against Mycobacterium tuberculosis in Hainan, China. doi:10.3390/pathogens14030218 Pathogens 2025
GrcC1 mediates low-level resistance to multiple drugs in M. marinum, M. abscessus, and M. smegmatis. doi:10.1128/spectrum.02289-24 Microbiol Spectr 2025
Prevalence and genetic insights of linezolid resistance in tuberculosis: A study of sensitive and resistant clinical isolates. doi:10.1016/j.diagmicrobio.2025.116719 Diagn Microbiol Infect Dis 2025
Agreement between Phenotypically Detected Linezolid Resistance and Mutations in rrl and rplC Genes of Mycobacterium tuberculosis Isolates Using Nanopore Sequencing. doi:10.4103/ijmy.ijmy_139_24 names it Int J Mycobacteriol 2024
Discovery of anti-Mycobacterium tuberculosis desertomycins from Streptomyces flavofungini TRM90047 based on genome mining and HSQC-TOCSY. doi:10.1038/s41598-024-65702-0 Sci Rep 2024
Phenotypic drug-susceptibility profiles and genetic analysis based on whole-genome sequencing of Mycobacterium avium complex isolates in Thailand. doi:10.1371/journal.pone.0294677 PLoS One 2023
Characterization of In Vitro Resistance to Linezolid in Mycobacterium abscessus. doi:10.1128/spectrum.02199-23 Microbiol Spectr 2023
Mechanisms of Linezolid Resistance in Mycobacteria. doi:10.3390/ph16060784 Pharmaceuticals (Basel) 2023
Epidemiology of Nontuberculous Mycobacteria in Nanjing and MAB_0540 Mutations Associated with Clofazimine Resistance in Mycobacterium abscessus. doi:10.2147/IDR.S408986 Infect Drug Resist 2023
Evaluation of genetic mutations associated with phenotypic resistance to fluoroquinolones, bedaquiline, and linezolid in clinical Mycobacterium tuberculosis: A systematic review and meta-analysis. doi:10.1016/j.jgar.2023.05.001 J Glob Antimicrob Resist 2023
Novel oxazolidinones harbor potent in vitro activity against the clinical isolates of multidrug-resistant Mycobacterium tuberculosis in China. doi:10.3389/fmed.2022.1067516 Front Med (Lausanne) 2022
Mutation detection and minimum inhibitory concentration determination against linezolid and clofazimine in confirmed XDR-TB clinical isolates. doi:10.1186/s12866-022-02622-x BMC Microbiol 2022
IgA Serological Response for the Diagnosis of Mycobacterium abscessus Infections in Patients with Cystic Fibrosis. doi:10.1128/spectrum.00192-22 Microbiol Spectr 2022
First report of whole-genome analysis of an extensively drug-resistant Mycobacterium tuberculosis clinical isolate with bedaquiline, linezolid and clofazimine resistance from Uganda. doi:10.1186/s13756-022-01101-2 Antimicrob Resist Infect Control 2022
Serological biomarkers for the diagnosis of Mycobacterium abscessus infections in cystic fibrosis patients. doi:10.1016/j.jcf.2021.08.019 J Cyst Fibros 2022
In vitro Antimicrobial Activity Comparison of Linezolid, Tedizolid, Sutezolid and Delpazolid Against Slowly Growing Mycobacteria Isolated in Beijing, China. doi:10.2147/IDR.S332835 Infect Drug Resist 2021
Linezolid resistance in Mycobacterium tuberculosis isolates at a tertiary care centre in Mumbai, India. doi:10.4103/ijmr.IJMR_1168_19 Indian J Med Res 2021
Genetic Profile of Linezolid-Resistant M. tuberculosis Clinical Strains from Moscow. doi:10.3390/antibiotics10101243 Antibiotics (Basel) 2021
RiskRadar: development and pilot results of a technical intervention targeting combination prevention regarding HIV, viral hepatitis, sexually transmitted infections and tuberculosis. doi:10.1186/s12879-021-06501-0 BMC Infect Dis 2021
Prevalence of extensively drug-resistant tuberculosis in a Chinese multidrug-resistant TB cohort after redefinition. doi:10.1186/s13756-021-00995-8 Antimicrob Resist Infect Control 2021
Comparison of the in vitro activity of linezolid, tedizolid, sutezolid, and delpazolid against rapidly growing mycobacteria isolated in Beijing, China. doi:10.1016/j.ijid.2021.06.055 Int J Infect Dis 2021
Prevalence of Mycobacterium tuberculosis resistant to bedaquiline and delamanid in China. doi:10.1016/j.jgar.2021.06.007 J Glob Antimicrob Resist 2021
Linezolid resistance among multidrug-resistant Mycobacterium tuberculosis clinical isolates in Iran. doi:10.1556/030.2021.01490 Acta Microbiol Immunol Hung 2021
Low Rate of Acquired Linezolid Resistance in Multidrug-Resistant Tuberculosis Treated With Bedaquiline-Linezolid Combination. doi:10.3389/fmicb.2021.655653 Front Microbiol 2021
Molecular characterization of multidrug-resistant tuberculosis against levofloxacin, moxifloxacin, bedaquiline, linezolid, clofazimine, and delamanid in southwest of China. doi:10.1186/s12879-021-06024-8 BMC Infect Dis 2021
Genetic and Virulence Characteristics of Linezolid and Pretomanid Dual Drug-Resistant Strains Induced from Mycobacterium tuberculosis in vitro. doi:10.2147/IDR.S257145 Infect Drug Resist 2020
Systematic review of mutations associated with resistance to the new and repurposed Mycobacterium tuberculosis drugs bedaquiline, clofazimine, linezolid, delamanid and pretomanid. doi:10.1093/jac/dkaa136 J Antimicrob Chemother 2020
Efflux Pumps Contribute to Intrinsic Clarithromycin Resistance in Clinical, Mycobacterium abscessus Isolates. doi:10.2147/IDR.S239850 Infect Drug Resist 2020
Characterization of linezolid-resistance-associated mutations in Mycobacterium tuberculosis through WGS. doi:10.1093/jac/dkz150 J Antimicrob Chemother 2019
Isolation and bioactive evaluation of flavonoid glycosides from Lobelia chinensis Lour using two-dimensional liquid chromatography combined with label-free cell phenotypic assays. doi:10.1016/j.chroma.2019.04.073 J Chromatogr A 2019
Linezolid resistance in patients with drug-resistant TB and treatment failure in South Africa. doi:10.1093/jac/dkz206 J Antimicrob Chemother 2019
Collated data of mutation frequencies and associated genetic variants of bedaquiline, clofazimine and linezolid resistance in Mycobacterium tuberculosis. doi:10.1016/j.dib.2018.09.057 Data Brief 2018
In vitro approaches for generation of Mycobacterium tuberculosis mutants resistant to bedaquiline, clofazimine or linezolid and identification of associated genetic variants. doi:10.1016/j.mimet.2018.08.011 J Microbiol Methods 2018
Comparison of In Vitro Activity and MIC Distributions between the Novel Oxazolidinone Delpazolid and Linezolid against Multidrug-Resistant and Extensively Drug-Resistant Mycobacterium tuberculosis in China. doi:10.1128/AAC.00165-18 Antimicrob Agents Chemother 2018
In Vitro Isolation and Characterization of Oxazolidinone-Resistant Mycobacterium tuberculosis. doi:10.1128/AAC.01296-17 Antimicrob Agents Chemother 2017
Activity of LCB01-0371, a Novel Oxazolidinone, against Mycobacterium abscessus. doi:10.1128/AAC.02752-16 Antimicrob Agents Chemother 2017
Performance of TaqMan array card to detect TB drug resistance on direct specimens. doi:10.1371/journal.pone.0177167 PLoS One 2017
Examination of bedaquiline- and linezolid-resistant Mycobacterium tuberculosis isolates from the Moscow region. doi:10.1093/jac/dkx094 J Antimicrob Chemother 2017
Role of the Cys154Arg Substitution in Ribosomal Protein L3 in Oxazolidinone Resistance in Mycobacterium tuberculosis. doi:10.1128/AAC.00152-16 Antimicrob Agents Chemother 2016
Beijing genotype of Mycobacterium tuberculosis is significantly associated with linezolid resistance in multidrug-resistant and extensively drug-resistant tuberculosis in China. doi:10.1016/j.ijantimicag.2013.12.007 Int J Antimicrob Agents 2014
[Quantitative proteomic analysis of streptomycin resistant and sensitive clinical isolates of Mycobacterium tuberculosis]. Wei Sheng Wu Xue Bao 2013
rplC T460C identified as a dominant mutation in linezolid-resistant Mycobacterium tuberculosis strains. doi:10.1128/AAC.06227-11 names it Antimicrob Agents Chemother 2012

Title+abstract index only: a paper that names this gene solely in its body text, a figure legend or a supplement is invisible here. That is why this list sits beside the curated layer rather than replacing it - Rv0007's characterisation, found by a full-text sweep, returns zero in this one. Absence from this list is not absence from the literature. Source: PubMed E-utilities sweep (esearch + esummary), every alias of the gene searched in conjunction with a mycobacterial context term; ambiguous common-word aliases excluded. phase198, 2026-09-06.

This layer CITES the literature and adds context; it does not change the verdict or the function stated elsewhere in this fiche. This distinguishes a gene that is dark because nobody has looked from one that is dark despite having been studied. Source: PubMed (whole): H37Rv locus tag + GENE NAME + ortholog identifiers (Mb…, MMAR_…, MSMEG_…, ML…, MAB_…), under a mycobacterial context filter; hits verified against the abstract text. Species-context counts distinguish M. tuberculosis literature from literature on other mycobacteria. phase76/phase77, 2026-07-13.

Genomic-neighbour overlap (structural caveat) co-directional · 0 % of gene

NeighbourrplD (Rv0702, + strand)
Overlap1 bp, 0 % of this gene's length

co-directional overlap: ordinary (e.g. shared stop/start codons in an operon), not the Rv2438A-type artefact P20.1, derived from GFF3 gene coordinates, 2026-08-03.

Conditional expression context (iModulons)

Member of 1 independently-modulated gene set(s): WhiB1 (whiB1).

iModulon membership (independently-modulated gene sets from a 647-sample RNA-seq compendium): the conditional co-expression context. Co-expression is a regulatory context, NOT a molecular function. Source: iModulonDB / modulome_mtb (Yoo 2022).

CRISPRi vulnerability

Vulnerability index -15.71 (95% CI -16.61 to -14.72). A more negative index = more vulnerable to knockdown (better drug-target quality); indicative threshold VI ≤ -6 = highly vulnerable.

Quantitative CRISPRi knockdown, graded (finer than binary Tn-seq essentiality). Source: CRISPRi vulnerability index (Bosch 2021, supplementary Table S2 'mmc3.xlsx', bulk import via Europe PMC -- supersedes the per-gene pebble.rockefeller.edu scrape of phase46_crispri_vulnerability.py).

Legacy record & comparison (Mycobrowser)

Mycobrowser functionThis protein binds directly to 23S ribosomal RNA and may participate in the formation of the peptidyltransferase center of the ribosome.

The legacy Mycobrowser record is shown for verification. Mycobrowser is no longer maintained; its EC numbers predate recent nomenclature revisions, so a class change usually reflects re-numbering, not a conflict.

Orthologues (reciprocal best hits across mycobacteria)

M. bovis Mb0721 · 100.0% identity
M. leprae ML1863c · 93.1% identity
M. marinum MMAR_1031 · 94.9% identity
M. smegmatis MSMEG_1436 · 88.0% identity
M. orygis RJtmp_000739 · 100.0% identity
M. abscessus MAB_3820c · 86.3% identity

Reciprocal-best-hit orthologues (DIAMOND) against the Mycobrowser reference proteomes. A missing species is informative: e.g. a gene absent from M. leprae was likely lost in its reductive genome evolution. Locus tags link to Mycobrowser.

Curated reference (UniProt)

UniProt P9WH87 SwissProt · reviewed · Evidence at protein level
UniProt nameLarge ribosomal subunit protein uL3
Curated functionOne of the primary rRNA binding proteins, it binds directly near the 3'-end of the 23S rRNA, where it nucleates assembly of the 50S subunit.

Functional vocabulary (eggNOG-mapper, orthology transfer)

COG category J Translation, ribosomal structure and biogenesis
Preferred namerplC
eggNOG descriptionOne of the primary rRNA binding proteins, it binds directly near the 3'-end of the 23S rRNA, where it nucleates assembly of the 50S subunit
Orthologous groupCOG0087
KEGG orthology K02906
KEGG pathways map03010
KEGG modules M00178, M00179
Gene Ontology (13) GO:0005575, GO:0005622, GO:0005623, GO:0005737, GO:0005829, GO:0005886, GO:0008150, GO:0016020, GO:0040007, GO:0044424, GO:0044444, GO:0044464 +1 more

Orthology-based transfer (eggNOG 5.0.2, diamond). EC/KO/GO/CAZy are computed annotations, not manual curation; cross-check against the primary literature before treating a specific reaction as established.

Conservation & selection (intra-MTBC, 142 601 strains, snapshot of 2026-09-29)

pN/pS 0.349 · purifying
Polymorphic sites (≥ 0.1% of strains) 4 synonymous, 4 missense, 0 nonsense, 0 frameshift

pN/pS from segregating SNPs (singletons removed) normalised by possible sites. Low pN/pS = purifying selection (a strong signal that a "hypothetical" is a real, constrained gene). A high pN/pS is ambiguous: relaxed constraint or positive selection (drug resistance, antigenic variation) inflate it; e.g. rpoB/katG/pncA score high here for resistance, not loss of function. A clonal disruption (one allele over a clade) suggests lineage pseudogenisation; a convergent one (many independent alleles) is typical of resistance loss-of-function.

Outgroup conservation (beyond the MTBC) Bacteria

M. canettii dN/dS (deep-divergence selection) 0.0 (low power) · 3 consensus substitution(s)
low power (3 canettii-consensus substitution(s)); present in M. canettii but dN/dS not reliable
Limitation: dN/dS mixes fixed canettii-H37Rv divergence with intra-canettii polymorphism, and is not polarised (the per-gene repolarisation is not viable: 79 % of the consensus SPDI lie outside the polarised table).
Genus-wide presence (~53 non-MTBC Mycobacterium) present in 53/53 (100%) · mean identity 93.6% · 4/4 closest MTBAP relatives
conserved across the genus (present in 53/53 non-MTBC Mycobacterium genomes, incl. distant relatives) — an ancient core gene predating the genus radiation
Phylostratum (deepest detected homolog) MTBC-specific → Mycobacterium → Mycobacteriaceae → Corynebacteriales → Actinomycetia → Bacteria
detected in 13/13 non-Mycobacterium reference genomes (down to Bacteria) · mean identity 68.1%
detected down to outside the phylum (Proteobacteria/Firmicutes controls) — a universally conserved, ancient bacterial gene

Two orthogonal outgroup signals. M. canettii (the immediate outgroup) gives a deep-divergence dN/dS (a low value confirms a constrained, real gene; shown as confident only at ≥8 substitutions, else flagged low-power). Genus-wide presence/absence (tblastn vs assembled non-MTBC genomes) places the gene on the ancient-core ↔ MTBC-specific axis: a gene absent even from the closest MTBAP relatives is a candidate MTBC-specific innovation (possible host-adaptation factor, to confirm by synteny). The phylostratum extends that axis outside the genus (tblastn vs 13 reference genomes spanning Mycobacteriaceae → Corynebacteriales → Actinomycetia → outside the phylum): it is the deepest clade in which a homolog is still detected, i.e. a proxy for gene age. Read it with the null model in mind: a shallow (young) stratum can also reflect homology-detection failure for short or fast-evolving ORFs, so it is a descriptive axis, not a proof of novelty.

Essentiality (transposon mutagenesis) essential

DeJesus 2017 callES · essential
What the call meansessential: insertions absent across the whole ORF
TA sites (Himar1) 16 in the ORF — 16 in the essential state, 0 growth-defect, 0 non-essential, 0 growth-advantage. Saturation 0.000, mean read count 0. A region of the protein devoid of TA sites is invisible to this assay: nothing can be inferred about it, in either direction.
All 16 sites lie in this ORF alone (no overlapping CDS shares any), so the call is attributable to this gene.

Genome-wide Himar1 transposon essentiality in H37Rv (DeJesus 2017). An essential call (ES/ESD/GD) is strong, independent evidence that a "hypothetical" locus encodes a functional, selectively required gene — orthogonal to intra-species conservation.

Chemical-genetic target & druggability (PROSPECT) hypomorph tool strain

This gene is part of the PROSPECT collection of TetON transcriptional-knockdown (hypomorph) strains of essential M. tuberculosis genes, built as a sensitised background for chemical-genetic mechanism-of-action deconvolution. Being in the panel means the gene is an essential / vulnerable target for which a validated knockdown tool strain exists.

Hypomorph strainRv0701 (rplC) -FLAG-DAS + pTetON-18-sspB (TetON promoter 18)
Baseline knockdown fitness2.767 median doublings (across 6 screen pool(s)) — fewer doublings = stronger growth defect on knockdown
Used in target deconvolutionyes (informs phenotypic-cluster / MOA assignment)

Panel membership reflects essentiality/vulnerability and the availability of a genetic tool, not a specific molecular function; it never changes the verdict here. Source: Bond AN et al., Nat Commun 2025;16:9673 (doi:10.1038/s41467-025-64662-x); PROSPECT chemical-genetic platform.

Drug resistance (WHO catalogue) linezolid

linezolid2 catalogued resistance-associated variant(s)

This gene carries mutations classed Associated with resistance (WHO grade 1–2) in the consolidated catalogue (WHO 2nd ed. 2023 + tb-profiler). Only the R-associated tier is shown; "uncertain" and empirical-only signals are excluded. Test a specific strain or variant with the resistance tester. Research context, not a clinical diagnostic.

Proteomics (mass spectrometry) detected

MS detectiondetected in 15 of 16 independent MS datasets
Integrated abundance1376.0 ppm · rank 155/3519 (95.6th percentile)

Detection by mass spectrometry is direct, experimental evidence that the protein product exists — orthogonal to sequence conservation and to Tn-seq essentiality, and especially decisive for a "hypothetical" locus. Read the dataset count as abundance, not as replication. Measured across this atlas (3,491 detected proteins), the number of datasets a protein appears in tracks its abundance almost monotonically: median 1.2 ppm at 1 dataset of 16, 27 ppm at 10, 392 ppm at 15, 1,325 ppm at 16 — three orders of magnitude. A high count therefore says the protein is abundant more than it says several independent experiments confirmed it. What the count does establish, at any value, is that the product exists.

Predicted localisation (DeepTMHMM + lipobox) no export signal, no TM helix

Predictionno signal peptide, no TM helix (DeepTMHMM class GLOB)
DeepTMHMM classGLOB

A verified absence of signals, which is not a compartment. No Sec/Tat signal peptide, no transmembrane helix and no lipobox were found on this sequence. The predictor reports topology and export signals; it does not measure where the protein ends up, so this page draws no cytoplasmic conclusion from it. In M. tuberculosis that reservation is not theoretical: the 12 Esx paralogues of this atlas — EsxA/ESAT-6 and EsxB/CFP-10 among them, the best-established secreted proteins of the species — carry this very call, because substrates of the type VII (ESX) secretion system leave no recognisable signal. « Secreted » and « no signal peptide » are true together here.

Transmembrane topology and signal peptide from DeepTMHMM (deep-learning reference predictor); lipoproteins from a (myco)bacterial lipobox motif. A sequence-based prediction of subcellular context.

Physico-chemical properties (computed, ProtParam)

Length217 aa
Molecular weight23.1 kDa
Theoretical pI10.3
GRAVY-0.308 (hydrophilic)
Aliphatic index79.5
Aromaticity0.051
Instability index19.3 (stable)

Computed from the ancestral MTBC0 sequence with the ExPASy ProtParam method (Biopython). Descriptive biophysical context: a positive GRAVY flags a hydrophobic (often membrane) protein, a high instability index (>40) predicts a short in-vitro half-life, an extreme pI hints at compartment or binding partner.

Domains (Pfam, hmmscan --cut_ga)

PfamAccessioni-EvalueResiduesDescription
Ribosomal_L3PF00297.29 2.5e-1792–187 Ribosomal protein L3

3D structure (interactive — Mol*/pdbe-molstar)

Experimental structure 7kgb (PDBe), the strongest available structural evidence for this gene. Drag to rotate, scroll to zoom; hetero-groups (ligands, ions, waters hidden by default) shown as sticks.

Experimental structures (Protein Data Bank) 11 solved

PDBMethodResolutionCoverage
7kgb Electron Microscopy 2.7 Å 100%
7mt7 Electron Microscopy 2.71 Å 100%
7mt2 Electron Microscopy 2.76 Å 100%
7msm Electron Microscopy 2.79 Å 100%
7mt3 Electron Microscopy 2.8 Å 100%
7msc Electron Microscopy 2.97 Å 100%
7msz Electron Microscopy 3.1 Å 100%
7msh Electron Microscopy 3.23 Å 100%

Experimentally solved structures mapped from the UniProt accession via PDBe/SIFTS (11 total; up to 8 shown, ranked by sequence coverage then resolution). An experimental structure is direct proof of the folded product and the strongest structural evidence — superseding the predicted ESMFold/AlphaFold models below for any covered region.

Structural search (AlphaFold DB model, Foldseek vs PDB — genome-wide) pLDDT 94.2

PDB hitprobTM (aln)TM (query)TM (target)Seq. id.Cov. q / tE-valueDescription
5o60-assembly1_D 1.00 1.00 0.98 0.99 88% 98% / 100% 1.1e-34 sig 5o60-assembly1_D Structure of the 50S large ribosomal subunit from Mycobacterium smegmatis
8wic-assembly1_F 1.00 0.99 0.95 0.99 86% 97% / 100% 9.2e-34 sig 8wic-assembly1_F Cryo- EM structure of Mycobacterium smegmatis 50S ribosomal subunit (body 1) of 70S ribosome, E- tRNA and RafH.
5v7q-assembly1_D 1.00 0.97 0.95 0.97 100% 98% / 100% 5.5e-33 sig 5v7q-assembly1_D Cryo-EM structure of the large ribosomal subunit from Mycobacterium tuberculosis bound with a potent linezolid analog
8cvm-assembly1_d 1.00 0.96 0.95 0.96 62% 99% / 99% 7.7e-31 sig 8cvm-assembly1_d Cutibacterium acnes 50S ribosomal subunit with P-site tRNA and Sarecycline bound in the local refined map
7p7q-assembly1_H 1.00 0.97 0.92 0.97 50% 97% / 100% 2.8e-25 sig 7p7q-assembly1_H E. faecalis 70S ribosome bound by PoxtA-EQ2, high-resolution combined volume

Foldseek search of the AlphaFold DB model (mean pLDDT 94.2, gated at 70) against the PDB — a genome-wide extension of the ESMFold dark-gene search that also covers proteins beyond the single-sequence length limit. Confident structural neighbours (E < 0.01) shown.

Genomic context (neighbours & predicted operon) operon of 4

Upstream (5' on genome)rpsJ (+ strand, 16 bp gap)
Downstream (3' on genome)rplD (+ strand, -1 bp gap)
Predicted operon rpsJ · rplC · rplD · rplW

Neighbours from the H37Rv annotation (+ strand). The operon is predicted by co-directional intergenic distance (same strand, gaps ≤50 bp) — a transcription-unit hypothesis, not a mapped TSS. For a "hypothetical", co-transcription with a characterised operon is a concrete functional lead (complements the STRING neighborhood channel below).

Published operon evidence (two independent sources)

Roback 2007 (logistic regression: distance + expression correlation, 474 microarrays) operon of 11: rpsJ · rplC · rplD · rplW · rplB · rpsS · rplV · rpsC · rplP · rpmC · rpsQ — disagrees with the distance heuristic above
REMap 2016 (RNA-seq coverage continuity, CDC1551, tag MT0728) exponential phase: operon of 12, Rv0700 · Rv0701 · Rv0702 · Rv0703 · Rv0704 · Rv0705 · Rv0706 · Rv0707 · Rv0708 · Rv0709 · Rv0710 · Rv0711 (coverage 131.3)
stationary phase: operon of 11, Rv0700 · Rv0701 · Rv0702 · Rv0703 · Rv0704 · Rv0705 · Rv0706 · Rv0707 · Rv0708 · Rv0709 · Rv0710 (coverage 19.19) — disagrees with the distance heuristic above

Two independent published operon maps, cited alongside the distance heuristic above: an association corroborating or contradicting the heuristic, never proof of shared function. REMap's RNA-seq coverage continuity is the most direct of the three signals; Roback's logistic regression and the intergenic-distance heuristic are statistical proxies.

Transcriptional regulation (signed TRN: ChIP-seq + TFOE)

Regulated by (1 TF) Rv1049 (activates)

Regulatory edges from the ISB signed transcriptional regulatory network (TF ChIP-seq binding, Minch 2015 + TF-overexpression response, Rustad 2014). An edge is regulatory evidence (binding and/or expression change), not necessarily direct. For a "hypothetical", membership in a known regulon (e.g. DosR dormancy, PhoP virulence) is a physiological-context lead, not a function.

Condition: Condition-blind by construction. These edges come from transcription-factor OVEREXPRESSION in a single laboratory condition, so a listed regulator is not a claim that it governs this gene in every circumstance. Measured counter-examples exist within this atlas (see Rv2516c, where the DosR regulon collapses under moxifloxacin while the gene itself rises). Read a regulator as 'capable of shifting this gene', and look for the condition before building a hypothesis on it.

Functional interaction network (STRING v12, guilt-by-association)

Explore full network →

Node colour = verdict, dashed = still uncharacterised; edge colour = evidence (green experimental, orange genomic-context, grey co-expression), width ∝ score. Click a partner to open its page; "Explore full network" to walk the graph.

Closest characterised functional partner: rplF (50S ribosomal protein L6), high confidence (score 1000, all STRING channels except text-mining; the partner is chosen on its genomic-context evidence). The pair's experimental or database support is transferred from orthologous pairs in other proteomes only: nothing was measured in M. tuberculosis, so it is an association inferred by orthology rather than measured in this organism.

Showing the 15 strongest of this gene's 369 partners at medium confidence (162 at high confidence). The table is an extract, not a neighbourhood: across the proteome the real median degree is 34 while the served median is 15, so no hub, degree distribution or centrality may be read on this table. None of the 369 partners rests on an interaction measured in M. tuberculosis itself.

PartnerProductScoreNo text-miningChannels (≥400)
Rv1015c rplY exp (transferred) 50S ribosomal protein L25/general stress protein Ctc 999 1000 coexpression:793 experimental:999
Rv0634B rpmG2 exp (transferred) 50S ribosomal protein L33 999 1000 coexpression:734 experimental:999
Rv0720 rplR exp (transferred) curated 50S ribosomal protein L18 999 1000 coexpression:891 experimental:999 database:758
Rv2441c rpmA exp (transferred) 50S ribosomal protein L27 999 1000 coexpression:886 experimental:999 textmining:588
Rv1298 rpmE exp (transferred) 50S ribosomal protein L31 999 1000 coexpression:708 experimental:999
Rv0719 rplF exp (transferred) curated 50S ribosomal protein L6 999 1000 ctx cooccurence:615 coexpression:967 experimental:999 database:733 textmining:618
Rv3443c rplM exp (transferred) curated 50S ribosomal protein L13 999 1000 ctx cooccurence:603 coexpression:885 experimental:999 database:685 textmining:598
Rv0702 rplD exp (transferred) curated 50S ribosomal protein L4 999 1000 ctx neighborhood:882 cooccurence:717 coexpression:975 experimental:999 database:585 textmining:924
Rv3456c rplQ exp (transferred) 50S ribosomal protein L17 999 1000 ctx cooccurence:574 coexpression:963 experimental:999
Rv2442c rplU exp (transferred) 50S ribosomal protein L21 999 1000 coexpression:864 experimental:999
Rv0707 rpsC exp (transferred) 30S ribosomal protein S3 999 1000 ctx neighborhood:739 coexpression:929 experimental:999 textmining:701
Rv0722 rpmD exp (transferred) curated 50S ribosomal protein L30 999 1000 coexpression:865 experimental:999 database:744
Rv0056 rplI exp (transferred) 50S ribosomal protein L9 999 1000 coexpression:861 experimental:999
Rv0723 rplO exp (transferred) curated 50S ribosomal protein L15 999 1000 ctx cooccurence:579 coexpression:911 experimental:999 database:758 textmining:582
Rv0700 rpsJ exp (transferred) 30S ribosomal protein S10 999 1000 ctx neighborhood:861 coexpression:985 experimental:999 textmining:591

STRING combines evidence channels (neighborhood, fusion, cooccurrence, coexpression, experimental, database, text-mining) into a 0–1000 score. The ctx badge marks edges carried by the genomic-context channels (conserved neighborhood, fusion, phylogenetic co-occurrence), which are independent of orthology and structure and the strongest signal for an unknown gene. The no text-mining column recomputes the score from data alone, so a link that does not depend on the literature is visible. Association is a function hypothesis, not proof: corroborate with the operon context and the primary literature before assigning a function.

Where the experimental evidence comes from, and why it matters here. STRING's experimental channel fuses interactions measured in M. tuberculosis with interactions measured in another organism and transferred to this pair by orthology. The two are not equivalent for this atlas, whose standing rule is that better studied elsewhere is not a function established in M. tuberculosis. Measured on the served network: of the 38 229 partner pairs shown across the atlas, 13 483 partner rows carry a non-zero experimental channel, and only 106 pairs rest on an interaction measured in M. tuberculosis itself — 0.3 % of the network. Those 106 are long-established complexes (ESX-1/ESAT-6, RNA polymerase with CarD and RbpA, the Pup–Mpa proteasome, gyrase, Emb, GarA with PknB and PknG, the Rel modules); no still-uncharacterised gene is among them. The reason is not a gap in this atlas but in the literature: there is almost no experimental interactome of this bacterium, IntAct holding 134 curated protein pairs for a ~4 000-gene proteome. A exp (transferred) badge is therefore a lead, never a measurement, and an absence of badge is not evidence that the pair does not interact.

Evidence

  • Legacy H37Rv annotation: 50S ribosomal protein L3
  • MTBC0 PGAP product: 50S ribosomal protein L3
  • Pfam (hmmscan --cut_ga): Ribosomal_L3 PF00297.29 (E=2e-17)
  • (auto-curated by rules from PGAP + Pfam + Foldseek; not hand-reviewed)

Sources

  • Ancestral sequence & coordinates: Harrison LB et al. (2024), An imputed ancestral reference genome for the MTBC, doi:10.1101/2023.09.07.556366
  • Product annotation: NCBI PGAP on MTBC0; legacy from H37Rv NC_000962.3 (RefSeq NP_215215.1)
  • Domains: Pfam-A via hmmscan --cut_ga — Ribosomal_L3 (PF00297.29)
  • Sequence-level signal: ESM Atlas (EvolutionaryScale × BioHub) — exploratory
  • Controlled vocabulary: eggNOG-mapper 2.1.12 (Cantalapiedra et al. 2021, doi:10.1093/molbev/msab293), eggNOG 5.0 DB (Huerta-Cepas et al. 2019) — OG COG0087
  • Curated reference: UniProt P9WH87 (SwissProt, reviewed; Evidence at protein level)
  • Intra-MTBC selection: pN/pS and disruption from SPDI variants of 142 601 MTBC strains (this work, local collection vs H37Rv NC_000962.3)
  • Genome-wide structure: AlphaFold DB model (Jumper et al. 2021, doi:10.1038/s41586-021-03819-2; Varadi et al. 2024, doi:10.1093/nar/gkad1011) searched vs PDB with Foldseek (mean pLDDT 94.2)
  • Interaction network: STRING v12.0 (Szklarczyk et al. 2023, doi:10.1093/nar/gkac1000), taxon 83332, CC-BY 4.0 — 369 functional partner(s); context anchor rplF
  • Essentiality: genome-wide transposon mutagenesis in H37Rv — DeJesus et al. 2017 (mBio, doi:10.1128/mBio.02133-16, CC BY)
  • Proteomics: integrated mass-spectrometry abundance from PaxDb 5.0 (Huang et al. 2023, doi:10.1016/j.mcpro.2023.100640), taxon 83332 — weighted average of 16 datasets, incl. Schubert et al. 2013 (doi:10.1016/j.chom.2013.04.008) and Albrethsen et al. 2013 (doi:10.1074/mcp.M112.018846)
  • Functional category: TubercuList scheme (Cole et al. 1998, doi:10.1038/31159), via Mycobrowser (Kapopoulou et al. 2011, doi:10.1016/j.tube.2010.09.006)
  • Orthologues: reciprocal best hits (DIAMOND, Buchfink et al. 2021, doi:10.1038/s41592-021-01101-x) against Mycobrowser release 5 reference proteomes
  • Experimental structures: PDBe/SIFTS UniProt→PDB mapping (Dana et al. 2019, doi:10.1093/nar/gky1114)
  • Genomic context / operon: H37Rv annotation; operon predicted by co-directional intergenic distance (Salgado et al. 2000, doi:10.1073/pnas.030539397)
  • Transcriptional regulation: ISB signed TRN — TF ChIP-seq (Minch et al. 2015, doi:10.1038/ncomms6829) + TF overexpression (Rustad et al. 2014, doi:10.1186/gb-2014-15-11-502)
  • Drug resistance: consolidated catalogue, WHO 2nd ed. 2023 (9789240082410) + tb-profiler; only the resistance-associated tier (grade 1–2) is surfaced
  • Physico-chemical properties: ExPASy ProtParam method via Biopython (Gasteiger et al. 2005), computed from the MTBC0 sequence
  • Predicted localisation: DeepTMHMM (Hallgren et al. 2022, doi:10.1101/2022.04.08.487609) for transmembrane topology and signal peptide
  • Primary literature: none located yet; annotation rests on the domain/homology sources above.

Ancestral MTBC0 protein sequence

>mtbc0_000743|Rv0701|rplC
MARKGILGTKLGMTQVFDESNRVVPVTVVKAGPNVVTRIRTPERDGYSAVQLAYGEISPRKVNKPLTGQYTAAGVNPRRYLAELRLDDSDAATEYQVGQELTAEIFADGSYVDVTGTSKGKGFAGTMKRHGFRGQGASHGAQAVHRRPGSIGGCATPARVFKGTRMAGRMGNDRVTVLNLLVHKVDAENGVLLIKGAVPGRTGGLVMVRSAIKRGEK